News From ASH 2017: MPN Updates From an Expert Panel

News From ASH 2017: MPN Updates From an Expert Panel

P2Professional

2 years
142 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
As part of our coverage from the 2017 American Society of Hematology (ASH) annual meeting, A super panel of MPN experts Dr. Mark Heaney, Dr. Rami Komrokji, Dr. Ruben Mesa, Dr. Jamile Shammo, as well as Andrew Schorr, gathered to discuss the latest news and developments related to research and treatment of myeloproliferative neoplasms (MPNs). The experts all shared their perspective on the headlines from this years meeting, including updates on JAK inhibitors in development, news on interferon, diagnostic testing, the story that somatic mutations tell, and the overwhelming interest in the study of MPNs.

Get email alerts | http://www.patientpower.info/alerts

Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo
Up Next Autoplay
ASH 2017: New Drugs and Numerous Drug Combinations in Myeloma
ASH 2017: New Drugs and Numerous Drug Combinations in Myeloma
Category: Acute Lymphoblastic Leukemia
1,300 Views
P2Professional 2 years
Treatment News in Lymphoma From ASH 2017
Treatment News in Lymphoma From ASH 2017
Category: Acute Lymphoblastic Leukemia
1,141 Views
P2Professional 2 years
Making Treatment Decisions in Myeloma: How Do I Know What’s Right for Me?
Making Treatment Decisions in Myeloma: How Do I Know What’s Right for Me?
Category: Acute Lymphoblastic Leukemia
974 Views
P2Professional 2 years
ROR1: An Update From ASH 2017
ROR1: An Update From ASH 2017
Category: Acute Lymphoblastic Leukemia
1,264 Views
P2Professional 2 years
ASH 2017: CLL Combination Therapy News
ASH 2017: CLL Combination Therapy News
Category: Acute Lymphoblastic Leukemia
1,057 Views
P2Professional 2 years
ASH 2017: Are Experts Personalizing Therapy to the Genetics of a Patient’s Myeloma?
ASH 2017: Are Experts Personalizing Therapy to the Genetics of a Patient’s Myeloma?
Category: Acute Lymphoblastic Leukemia
554 Views
P2Professional 2 years
CAR T-Cell Therapy Update From ASH 2017
CAR T-Cell Therapy Update From ASH 2017
Category: Acute Lymphoblastic Leukemia
175 Views
P2Professional 2 years
What the MPN Experts Learned at ASH 2017
What the MPN Experts Learned at ASH 2017
Category: Acute Lymphoblastic Leukemia
146 Views
P2Professional 2 years
ASH 2017: Promising Mantle Cell Lymphoma Treatment News
ASH 2017: Promising Mantle Cell Lymphoma Treatment News
Category: Acute Lymphoblastic Leukemia
404 Views
P2Professional 2 years
CAR T-Cell Therapy News From ASH 2017
CAR T-Cell Therapy News From ASH 2017
Category: Acute Lymphoblastic Leukemia
325 Views
P2Professional 2 years